SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Anthony @ Equity Investigations, Dear Anthony,
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Anthony@Pacific who wrote (5549)1/22/1999 11:43:00 AM
From: jjs64  Read Replies (1) of 122087
 
Here is SBTK's latest FDA violation...there are LOTS more. check fda.gov

FDA Enforcement Report

The FDA Enforcement Report is published weekly by the Food and Drug Administration, U.S. Public Health Service, Department of Health and Human Services. It contains information on actions taken in connection with agency regulatory activities.

December 23, 1998 98-51

RECALLS AND FIELD CORRECTIONS: DEVICES -- CLASS II

PRODUCT: Flush Syringe Combination Package, 10u/ml. Recall #Z-172-9.

CODE:Lot number 10080-0821-1310-FL.

MANFACTURER: ROCAP Division of Sabratek Corporation, Orlando, Florida.

REASON: Some syringes labeled 10u/mL heparin actually contained normal
saline.

Now that's quality control!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News